|
|||
 |
Inwood Laboratories, established in 1969, markets generic products as a
subsidiary of Forest Laboratories. Forest markets a variety of branded
pharmaceuticals including Namenda® for Alzheimer's disease, Lexapro®
for depression and GAD, and Benicar®/Benicar HCT® for
hypertension. Inwood markets generic pharmaceuticals to treat a variety of
illnesses. Following are the therapeutic categories served by Inwood products:
The majority of the Inwood portfolio are Forest authorized generics, meaning exact copies of Forest-branded products. For those products, the Inwood generic is approved for sale by the Food & Drug Administration (FDA) under the same New Drug Application (NDA) as the branded Forest product. To obtain more information on Inwood Laboratories, Inc. and their products and services, contact customer service at 1-800-685-5227. Click here to learn about Inwood Citalopram HBr. For more information about Forest Laboratories, please visit www.frx.com. |
